UroGen Pharma Ltd. short interest in 2019

In 2019, UroGen Pharma Ltd.'s disclosed short interest ran from 11.24% of shares outstanding on 15 Oct 2019 to 8.58% on 31 Dec 2019, a change of -2.66 percentage points. The year's high was 11.34% on 13 Dec 2019 and its low 8.58% on 31 Dec 2019, averaging 10.76% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.35 days on 31 Oct 2019. Full history: UroGen Pharma Ltd..

Cite this page

Plain

Short position data for UroGen Pharma Ltd. short interest in 2019: FINRA, compiled by howshorted.com, settlement date 31 Dec 2019. https://howshorted.com/us/company/urgn/2019/

Wikipedia

<ref>{{cite web |title=UroGen Pharma Ltd. short interest in 2019 short position data |url=https://howshorted.com/us/company/urgn/2019/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2019-12-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-urogen-pharma-ltd-short-interest-in-2019-2019-12-31,
  title        = {UroGen Pharma Ltd. short interest in 2019 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/urgn/2019/}},
  note         = {Data: FINRA, settlement date 31 Dec 2019; accessed 2026-10-13},
  year         = {2019}
}

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

2019 in figures

Start of year: 11.24% (15 Oct 2019)
End of year: 8.58% (31 Dec 2019)
Change: -2.66 pp
High: 11.34% (13 Dec 2019)
Low: 8.58% (31 Dec 2019)
Average: 10.76%
Highest days to cover: 17.35 (31 Oct 2019)
SEC filings marked: 9

Every report in 2019

UroGen Pharma Ltd. short interest in 2019
Settlement	Short interest	Days to cover	Filings since previous
15 Oct 2019	11.24%	8.95	results (8-K), 10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K)
31 Oct 2019	10.85%	17.35
15 Nov 2019	11.31%	12.59	10-Q filed, results (8-K)
29 Nov 2019	11.22%	12.07
13 Dec 2019	11.34%	16.21
31 Dec 2019	8.58%	11.52

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.